GOLDSTEIN JOSEPH L has filed 14 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 1962 shares of REGENERON PHARMACEUTICALS, INC. ($REGN) on January 02, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | GOLDSTEIN JOSEPH L | Director | A | Non-Qualified Stock Option (right to buy) | 1962 | $0.00 | 1,962.0000 | 137,600,000 | 9999.99% | 0.00% |
| Jan. 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | GOLDSTEIN JOSEPH L | Director | A | Common Stock | 155 | $0.00 | 6,703.0000 | 137,600,000 | 2.37% | 0.00% |
| Jan. 2, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | GOLDSTEIN JOSEPH L | Director | A | Common Stock | 166 | $0.00 | 6,548.0000 | 136,000,000 | 2.60% | 0.00% |
| Jan. 2, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | GOLDSTEIN JOSEPH L | Director | A | Non-Qualified Stock Option (right to buy) | 1958 | $0.00 | 1,958.0000 | 136,000,000 | 9999.99% | 0.00% |
| Jan. 23, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | GOLDSTEIN JOSEPH L | Director | M | Non-Qualified Stock Option (right to buy) | 2707 | $0.00 | 0.0000 | 133,100,000 | 100.00% | 0.00% |
| Jan. 23, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | GOLDSTEIN JOSEPH L | Director | S | Common Stock | 2707 | $950.00 | 6,382.0000 | 133,100,000 | 29.78% | 0.00% |
| Jan. 23, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | GOLDSTEIN JOSEPH L | Director | M | Common Stock | 2707 | $625.60 | 9,089.0000 | 133,100,000 | 42.42% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | GOLDSTEIN JOSEPH L | Director | A | Common Stock | 135 | $0.00 | 6,382.0000 | 133,100,000 | 2.16% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | GOLDSTEIN JOSEPH L | Director | A | Non-Qualified Stock Option (right to buy) | 1607 | $0.00 | 1,607.0000 | 133,100,000 | 9999.99% | 0.00% |
| Feb. 6, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | GOLDSTEIN JOSEPH L | Director | M | Non-Qualified Stock Option (right to buy) | 3613 | $0.00 | 0.0000 | 130,400,000 | 100.00% | 0.00% |
| Feb. 6, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | GOLDSTEIN JOSEPH L | Director | M | Common Stock | 3613 | $482.68 | 9,860.0000 | 130,400,000 | 57.84% | 0.00% |
| Feb. 6, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | GOLDSTEIN JOSEPH L | Director | S | Common Stock | 3613 | $800.00 | 6,247.0000 | 130,400,000 | 36.64% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | GOLDSTEIN JOSEPH L | Director | A | Common Stock | 165 | $0.00 | 6,247.0000 | 130,400,000 | 2.71% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | GOLDSTEIN JOSEPH L | Director | A | Non-Qualified Stock Option (right to buy) | 1929 | $0.00 | 1,929.0000 | 130,400,000 | 9999.99% | 0.00% |